Yahoo
HKSE - Delayed Quote HKD

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)

5.625 -0.025 (-0.44%)
At close: November 2 at 4:08:13 PM GMT+8
Chart Range Bar
Loading chart for 3613.HK
  • Previous Close 5.650
  • Open 5.650
  • Bid 5.630 x --
  • Ask 5.640 x --
  • Day's Range 5.590 - 5.690
  • 52 Week Range 5.400 - 9.500
  • Volume 499,000
  • Avg. Volume 1,110,186
  • Market Cap (intraday) 4.709B
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 13.08
  • EPS (TTM) 0.430
  • Earnings Date --
  • Forward Dividend & Yield 0.37 (6.55%)
  • Ex-Dividend Date Jun 12, 2026
  • 1y Target Est 9.75

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and Europe. The company was founded in 1669 and is based in Wan Chai, Hong Kong.

cm.tongrentang.com

763

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

3613.HK
29.68%
HANG SENG INDEX (^HSI)
8.73%

1-Year Return

3613.HK
30.90%
HANG SENG INDEX (^HSI)
9.70%

3-Year Return

3613.HK
45.96%
HANG SENG INDEX (^HSI)
35.77%

5-Year Return

3613.HK
29.31%
HANG SENG INDEX (^HSI)
6.80%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY17
Revenue 329.76M
Earnings 107.86M
Profit Margin 32.71%

Q1

FY17

Q2

FY17

Q3

FY17

Q4

FY17

0
100M
200M
300M
34.0%
36.0%
38.0%
40.0%
42.0%

Analyst Insights

View More

Analyst Price Targets

9.00
9.75 Average
5.625 Current
10.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.64%

  • Return on Assets (ttm)

    5.89%

  • Return on Equity (ttm)

    8.80%

  • Revenue (ttm)

    1.35B

  • Net Income Avi to Common (ttm)

    360.55M

  • Diluted EPS (ttm)

    0.430

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.22B

  • Total Debt/Equity (mrq)

    2.97%

  • Levered Free Cash Flow (ttm)

    512M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: